Pakyz Amy L, Moczygemba Leticia R, Wang Hui, Stevens Michael P, Edmond Michael B
Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA
Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.
J Antimicrob Chemother. 2015 May;70(5):1588-91. doi: 10.1093/jac/dku555. Epub 2015 Jan 21.
To determine whether an antimicrobial stewardship 'intensity' score predicts hospital antimicrobial usage.
An antimicrobial stewardship score for 44 academic medical centres was developed that comprised two main categories: resources (antimicrobial stewardship programme personnel and automated surveillance software) and strategies (preauthorization, audit with intervention and feedback, education, guidelines and clinical pathways, parenteral to oral therapy programmes, de-escalation of therapy, antimicrobial order forms and dose optimization). Multiple regression analyses were used to assess whether the composite score and also the categories were associated with either total or antimicrobial stewardship programme-target antimicrobial use as measured in days of therapy.
The mean antimicrobial stewardship programme score was 55 (SD 21); the total composite score was not significantly associated with total or target antimicrobial use [estimate -0.49 (95% CI -2.30 to 0.89)], while the category strategies was significantly and negatively associated with target antimicrobial use [-5.91 (95% CI -9.51 to -2.31)].
The strategy component of a score developed to measure the intensity of antimicrobial stewardship was associated with the amount of antimicrobials used. Thus, the number and types of strategies employed by antimicrobial stewardship programmes may be of particular importance in programme effectiveness.
确定抗菌药物管理“强度”评分是否能预测医院抗菌药物的使用情况。
为44家学术医疗中心制定了抗菌药物管理评分,该评分包括两个主要类别:资源(抗菌药物管理项目人员和自动化监测软件)和策略(预授权、干预与反馈的审核、教育、指南和临床路径、肠外给药改为口服给药方案、治疗降阶梯、抗菌药物医嘱单和剂量优化)。采用多元回归分析来评估综合评分以及各个类别是否与以治疗天数衡量的总抗菌药物使用量或抗菌药物管理项目目标抗菌药物使用量相关。
抗菌药物管理项目的平均评分为55(标准差21);总综合评分与总抗菌药物使用量或目标抗菌药物使用量无显著相关性[估计值-0.49(95%置信区间-2.30至0.89)],而策略类别与目标抗菌药物使用量显著负相关[-5.91(95%置信区间-9.51至-2.31)]。
为衡量抗菌药物管理强度而制定的评分中的策略部分与抗菌药物使用量相关。因此,抗菌药物管理项目采用的策略数量和类型可能对项目效果尤为重要。